Plunkett Research Online: Protalex Inc

PROTALEX INC (PRTX:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Protalex Inc is a United States-based clinical stage company. It is primarily focused on the development of biopharmaceutical drugs for treating autoimmune and inflammatory diseases including rheumatoid arthritis and immune thrombocytopenia. The key product candidate of the group is PRTX-100, an imm.....



Protalex Inc
Ticker: PRTX
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 215 862-9720
Fax:
Address: 131 Columbia Turnpike
Suite 1
Florham Park, NJ 07932 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Scientific Research and Development (R&D) in Life Sciences, Medical Devices, Biotechnology and Pharmaceuticals (Drugs)
ContactsDescription
Arnold KlingCEO/Director/President
Kirk WarshawCFO/Chief Accounting Officer/Director/Secretary
See More
Protalex Inc is a United States-based clinical stage company. It is primarily focused on the development of biopharmaceutical drugs for treating autoimmune and inflammatory diseases including rheumatoid arthritis and immune thrombocytopenia. The key product candidate of the group is PRTX-100, an imm.....See More See More

Auditor: Liggett & Webb, P.A
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201820172016201520142013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: